Taking the "Public" Out of Public Reporting of Percutaneous Coronary Intervention.
作者信息
Wadhera Rishi K, Bhatt Deepak L
机构信息
Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA. 2017 Oct 17;318(15):1439-1440. doi: 10.1001/jama.2017.12087.
Abstract
摘要
相似文献
1
Taking the "Public" Out of Public Reporting of Percutaneous Coronary Intervention.将经皮冠状动脉介入治疗的公开报告中的“公开”部分去除。
JAMA. 2017 Oct 17;318(15):1439-1440. doi: 10.1001/jama.2017.12087.
2
Does public reporting improve the quality of hospital care for acute myocardial infarction? Results from a regional outcome evaluation program in Italy.公开报告能否提高急性心肌梗死的医院护理质量？意大利一项区域结果评估计划的结果。
Int J Qual Health Care. 2014 Jun;26(3):223-30. doi: 10.1093/intqhc/mzu041. Epub 2014 Apr 15.
3
Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.欧洲心脏病学会和欧洲心胸外科学会指南对稳定型冠状动脉疾病血运重建策略的影响：经皮冠状动脉介入治疗和冠状动脉旁路移植术的活动变化。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):606-10. doi: 10.1016/j.jtcvs.2013.01.026. Epub 2013 Feb 10.
4
High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications.公共报告州的高风险经皮冠状动脉介入治疗：证据、重症患者排除及影响
Curr Heart Fail Rep. 2017 Dec;14(6):514-518. doi: 10.1007/s11897-017-0369-1.
5
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association.经皮冠状动脉介入治疗绩效报告对心脏复苏中心的影响：美国心脏协会的科学声明
Circulation. 2013 Aug 13;128(7):762-73. doi: 10.1161/CIR.0b013e3182a15cd2. Epub 2013 Jul 15.
6
Public reporting and coronary revascularization: risk and benefit.
Coron Artery Dis. 2014 Nov;25(7):619-26. doi: 10.1097/MCA.0000000000000169.
7
Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo.经皮冠状动脉介入治疗结果的公众报告：超越现状。
JAMA Cardiol. 2018 Jul 1;3(7):635-640. doi: 10.1001/jamacardio.2018.0947.
8
Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program.在一个地区性的直接经皮冠状动脉介入治疗项目中，不恰当及假阳性的心导管实验室激活事件的发生率和特征。
Am Heart J. 2016 Mar;173:126-33. doi: 10.1016/j.ahj.2015.10.027. Epub 2015 Dec 28.
9
Quality and Safety in Health Care, Part XXXVIII: The CathPCI Registry.《医疗保健中的质量与安全》第三十八部分：经皮冠状动脉介入治疗（PCI）登记研究。
Clin Nucl Med. 2018 Aug;43(8):586-588. doi: 10.1097/RLU.0000000000002038.
10
Appropriate coronary artery bypass grafting use in the percutaneous coronary intervention era: are we finally making progress?经皮冠状动脉介入治疗时代合适的冠状动脉旁路移植术应用：我们最终是否取得了进展？
Semin Thorac Cardiovasc Surg. 2012 Winter;24(4):241-3. doi: 10.1053/j.semtcvs.2012.11.005.
引用本文的文献
1
Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among US Hospitals.美国医院中ST段抬高型心肌梗死患者接受经皮冠状动脉介入治疗可能性的差异
J Am Heart Assoc. 2025 Mar 4;14(5):e038317. doi: 10.1161/JAHA.124.038317. Epub 2025 Feb 19.
2
Influence of Major Adverse Events on Procedural Selection for Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Program.主要不良事件对经皮冠状动脉介入治疗程序选择的影响：来自退伍军人事务部临床评估报告与跟踪项目的见解
J Soc Cardiovasc Angiogr Interv. 2022 Oct 21;1(6):100460. doi: 10.1016/j.jscai.2022.100460. eCollection 2022 Nov-Dec.
3
Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.医院在评估急性心肌梗死患者基于疾病的死亡率与手术死亡率方面的表现。
JAMA Cardiol. 2020 Jul 1;5(7):765-772. doi: 10.1001/jamacardio.2020.0753.
4
Association Between Current and Future Annual Hospital Percutaneous Coronary Intervention Mortality Rates.当前和未来年度医院经皮冠状动脉介入治疗死亡率之间的关联。
JAMA Cardiol. 2019 Nov 1;4(11):1077-1083. doi: 10.1001/jamacardio.2019.3221.
5
Public Reporting of Percutaneous Coronary Intervention Outcomes: Institutional Costs and Physician Burden.经皮冠状动脉介入治疗结果的公开报告：机构成本与医生负担
J Am Coll Cardiol. 2019 May 28;73(20):2604-2608. doi: 10.1016/j.jacc.2019.03.014. Epub 2019 Mar 15.
6
Association of Rankings With Cardiovascular Outcomes at Top-Ranked Hospitals vs Nonranked Hospitals in the United States.美国排名顶尖医院与非排名医院的排名与心血管结局的关系。
JAMA Cardiol. 2018 Dec 1;3(12):1222-1225. doi: 10.1001/jamacardio.2018.3951.
7
Inadequate Surrogates for Imperfect Quality Measures.不完美质量指标的不充分替代指标。
Circ Cardiovasc Interv. 2018 Sep;11(9):e007216. doi: 10.1161/CIRCINTERVENTIONS.118.007216.
8
Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo.经皮冠状动脉介入治疗结果的公众报告：超越现状。
JAMA Cardiol. 2018 Jul 1;3(7):635-640. doi: 10.1001/jamacardio.2018.0947.
本文引用的文献
1
Patient and Physician Perspectives on Public Reporting of Mortality Ratings for Percutaneous Coronary Intervention in New York State.患者与医生对纽约州经皮冠状动脉介入治疗死亡率评级公开报告的看法。
Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). doi: 10.1161/CIRCOUTCOMES.116.003511.
2
Treatment and Outcomes of Acute Myocardial Infarction Complicated by Shock After Public Reporting Policy Changes in New York.纽约公共报告政策变化后急性心肌梗死合并休克患者的治疗及转归
JAMA Cardiol. 2016 Sep 1;1(6):648-54. doi: 10.1001/jamacardio.2016.1806.
3
Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting.纽约在将心原性休克排除在公共报告之外前后的有创性治疗率。
JAMA Cardiol. 2016 Sep 1;1(6):640-7. doi: 10.1001/jamacardio.2016.0785.
4
Collaborative quality improvement vs public reporting for percutaneous coronary intervention: A comparison of percutaneous coronary intervention in New York vs Michigan.经皮冠状动脉介入治疗的协作质量改进与公开报告：纽约州与密歇根州经皮冠状动脉介入治疗的比较
Am Heart J. 2015 Dec;170(6):1227-33. doi: 10.1016/j.ahj.2015.09.006. Epub 2015 Sep 16.
5
State mandated public reporting and outcomes of percutaneous coronary intervention in the United States.美国国家规定的经皮冠状动脉介入治疗的公开报告及结果
Am J Cardiol. 2015 Jun 1;115(11):1494-501. doi: 10.1016/j.amjcard.2015.02.050. Epub 2015 Mar 12.
6
Association between public reporting of outcomes with procedural management and mortality for patients with acute myocardial infarction.急性心肌梗死患者的手术管理结局公开报告与死亡率之间的关联。
J Am Coll Cardiol. 2015 Mar 24;65(11):1119-26. doi: 10.1016/j.jacc.2015.01.008.
7
Nonobstructive coronary artery disease and risk of myocardial infarction.非阻塞性冠状动脉疾病与心肌梗死风险
JAMA. 2014 Nov 5;312(17):1754-63. doi: 10.1001/jama.2014.14681.
8
Association of public reporting for percutaneous coronary intervention with utilization and outcomes among Medicare beneficiaries with acute myocardial infarction.经皮冠状动脉介入治疗的公共报告与医疗保险受益人的急性心肌梗死患者的利用和结局的关联。
JAMA. 2012 Oct 10;308(14):1460-8. doi: 10.1001/jama.2012.12922.
9
Impact of independent data adjudication on hospital-specific estimates of risk-adjusted mortality following percutaneous coronary interventions in massachusetts.
Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):92-8. doi: 10.1161/CIRCOUTCOMES.110.957597. Epub 2010 Dec 14.
Zotero 插件